Lovastatin Structural Formula (C9a957b3 1d7f 4f61 A7d7 38f2edbeb69b 01)
Lovastatin
Product Images NDC 68788-9180
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 68788-9180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Promotions of Participants without Event Chart)
The text seems to be a part of a graph or chart. It mentions the title of the figure, which is "Proportion of Participants Without Event" and the label of the y-axis as "Number of Major Coronary Events (Primary Endpoint)". It also gives the number "2 2 K" and "Years of Follow-up". It appears to be discussing a study or research on coronary events in relation to the follow-up period.*
Imprint (C9a957b3 1d7f 4f61 A7d7 38f2edbeb69b 03)
Lovastatin Tablets, Usp 10mg (C9a957b3 1d7f 4f61 A7d7 38f2edbeb69b 04)
Lovastatin Tablets are a medication used in the treatment of high cholesterol. They contain 10mg of Lovastatin, the generic version of Mevacor. The packaging size and expiration date are listed, along with the lot and batch numbers, and the manufacturer is Actavis Elizabeth LLC located in Elizabeth, NJ. The cautionary note mentions that federal law prohibits the transfer of medications to anyone other than the patient for whom it was prescribed. The other text includes various variations of basic information related to the medication including quantity, lot numbers, batch numbers, and prod/ND codes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
